Mox inhibits oxidative damage by upregulating NRF2-dependent antioxidant enzymes and producing GSH, which has been shown to be the main ATMs for lean AT (64, 138)
Schmieder 14 Christoph Wanner 15 David Z.I
Particularly noteworthy is that in patients with both type 2 diabetes and MASLD, after 24 weeks of treatment with a 10 mg dose of efinopegdutide, liver fat content reduced by 72.7%, a result that is superior to the 42.3% reduction achieved with a 1 mg dose of semaglutide, despite a similar overall weight loss being observed with the two interventions
In fact, most studies where people where given anti inflammatory meds, actually worsened cardiovascular outcomes: NSAIDs, steroids, canakinumab, and many others
For patients considering procedures such as SmartLipo or other body contouring surgeries, pre-operative weight loss achieved through GLP-1 treatments can enhance surgical outcomes
Yoon, H., Lee, H